Showing results (121-130 of 406) with videos related to

Sort By:
Pageof 41
ERJ Open Research|March 10, 2022
COPD mortality and exacerbations in the placebo group of clinical trials over two decades: a systematic review and meta-regressionStefan Andreas, Christian Röver, Judith Heinz, et al.
ESC Heart Failure|March 30, 2021
Effect of Carillon Mitral Contour System on patient-reported outcomes in functional mitral regurgitation: an individual participant data meta-analysisMuhammad Shahzeb Khan, Tim Friede, Stefan D Anker, et al.
Statistics in Medicine|March 25, 2020
Blinded sample size reestimation for negative binomial regression with baseline adjustmentAntonia Zapf, Thomas Asendorf, Christoph Anten, et al.
Pharmaceutical Statistics|May 18, 2021
Estimating and comparing adverse event probabilities in the presence of varying follow-up times and competing eventsRegina Stegherr, Claudia Schmoor, Michael Lübbert, et al.
Statistics in Medicine|February 27, 2009
Optimal choice of the number of treatments to be included in a clinical trialNigel Stallard, Martin Posch, Tim Friede, et al.
Pediatric Transplantation|October 7, 2014
Interleukin-2 receptor antagonists for pediatric liver transplant recipients: a systematic review and meta-analysis of controlled studiesNicola D Crins, Christian Röver, Armin D Goralczyk, et al.
Drugs & Aging|June 10, 2025
Real-World Harm Reduction of Metformin Plus DPP4 Inhibitors versus Metformin Plus Sulfonylureas in Older Adults: A Target Trial Emulation Using German Claims DataPaula Starke, Petra Thürmann, Thomas Grobe, et al.
BMC Medical Research Methodology|July 14, 2016
EFSPI/PSI working group on data sharing: accessing and working with pharmaceutical clinical trial patient level datasets - a primer for academic researchersRebecca Sudlow, Janice Branson, Tim Friede, et al.
Biometrical Journal. Biometrische Zeitschrift|November 26, 2016
Blinded versus unblinded estimation of a correlation coefficient to inform interim design adaptationsCornelia U Kunz, Nigel Stallard, Nicholas Parsons, et al.
Statistics in Medicine|June 27, 2015
Flexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trialNigel Stallard, Cornelia Ursula Kunz, Susan Todd, et al.
Pageof 41